Form 4: Allstate CEO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Allstate Corporation's Chairman, President, and CEO, Thomas J. Wilson, sold a total of 16,807 shares of common stock on January 2, 2026, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Thomas J. Wilson, Chairman, President & CEO of The Allstate Corporation, reported the sale of 16,807 shares of common stock.
- These sales occurred on January 2, 2026, at weighted average prices ranging from $204.0964 to $206.9005 per share.
- The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2025.
- Following these sales, Wilson's direct beneficial ownership decreased to 111,215.303 shares.
- Indirect beneficial ownership includes 31,900 shares by 2024-C GRAT, 69,822 shares by 2025-A GRAT, 94,729 shares by 2025-E GRAT, 7,681 shares by 401(k) Plan, 324,088 shares by 2020 GRAT Remainder Trust, and 257,535 shares by Remainder GRAT.
- An additional 16.812 shares were acquired between October 3, 2025, and January 2, 2026, through the Shareowner Service Plus Plan, which reinvests dividends.
Sentiment
Score: 5
Explanation: The filing reports routine insider sales executed under a pre-arranged 10b5-1 trading plan, which is generally considered a neutral event for market sentiment as it's for personal financial planning rather than a reaction to new company developments.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing is an insider transaction report and does not provide specific industry context or relate to broader industry trends or competitors beyond the individual's role within The Allstate Corporation.
Related Party Transactions
- The reporting person holds shares indirectly through various Grantor Retained Annuity Trusts (GRATs), including 2024-C GRAT, 2025-A GRAT, 2025-E GRAT, 2020 GRAT Remainder Trust, and Remainder GRAT, which are structures for estate planning.
Stakeholder Impact
- Shareholders may view insider sales, even under a 10b5-1 plan, with scrutiny, though the pre-arranged nature typically mitigates concerns about opportunistic selling based on non-public information.
Key Dates
| Date | Description |
|---|---|
| 06/27/2025 | Rule 10b5-1 trading plan adopted |
| 10/03/2025 | Start of period for dividend reinvestment through Shareowner Service Plus Plan |
| 01/02/2026 | Transaction date for common stock sales and end of dividend reinvestment period |
| 01/06/2026 | Signature date of the filing |
Recommendation
holdThe filing details routine insider sales by the CEO under a pre-arranged 10b5-1 trading plan. Such transactions are typically for personal financial planning and do not inherently signal a change in the company's fundamental outlook or warrant a shift from a 'hold' recommendation.
Keywords
Allstate, ALL, insider trading, Form 4, stock sale, Thomas J. Wilson, CEO, 10b5-1 plan, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.